Indianarise Pharmaceuticals Private Limited
About Indianarise Pharmaceuticals Private Limited
Data last updated:
Indianarise Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 03 March 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2014PTC265686. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Vijay Nath Tiwari and Jeetendra Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No. 363 First Floor Gali Chandi Wali Pahar Gan, J, New Delhi, Delhi, India – 110055.
As per the financials filed for FY 2017, the company reported a revenue of ₹15.22 Lakh, a growth of 138% compared to the previous year. For the same year it recorded a net profit of ₹32,290 (net margin 2.1%) and EBITDA of ₹42,290 (EBITDA margin 2.8%).
As per MCA filings, the company has open charges of ₹5 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Indianarise Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No. 363 First Floor Gali Chandi Wali Pahar Gan, J, New Delhi, Delhi, India – 110055
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Indianarise Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Indianarise Pharmaceuticals Private Limited
FY 2025 filings availableIndianarise Pharmaceuticals Private Limited reported revenue of ₹15.22 Lakh (up 138% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue rose 138% in the latest year. EBITDA rose 122% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹15.22 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹42,290 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹32,290 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 2.8% | ||
| Net Profit Margin | 2.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Indianarise Pharmaceuticals Private Limited, buy the company report.
Board of directors of Indianarise Pharmaceuticals Private Limited
Indianarise Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijay Nath Tiwari | Director | 03 Mar 2014 | 12 Years 8 Months | Current |
| Jeetendra Kumar | Director | 03 Mar 2014 | 12 Years 8 Months | Current |
| Shyam Pandey Narayan Also directs: Tantaa Pharmaceutical Private Limited | Director | 03 Mar 2014 | 12 Years 8 Months | Current |
| Rajendra Parsad Pandey | Director | 03 Mar 2014 | 12 Years 8 Months | Current |
Auditor
Indianarise Pharmaceuticals Private Limited is audited by SHAKTI SHARAN & COMPANY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHAKTI SHARAN & COMPANY | FY 2017 | 012809C |
Shareholding
The shareholding of Indianarise Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Indianarise Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Jul 2016 | 100043979 | Others | ₹5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Indianarise Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Indianarise Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Indianarise Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Indianarise Pharmaceuticals Private Limited, buy the company report.
Recent activity
Indianarise Pharmaceuticals Private Limited has 4 board changes on record since 2014: 4 appointments. The latest: Jeetendra Kumar was appointed as Director on 03 Mar 2014.
Frequently asked questions
Indianarise Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in chemical products, within the chemicals industry. It was incorporated on 03 March 2014 (12+ years old) and is registered under CIN U24233DL2014PTC265686.
Indianarise Pharmaceuticals has 4 current directors:
- Vijay Nath Tiwari - Director
- Jeetendra Kumar - Director
- Shyam Pandey Narayan - Director
- Rajendra Parsad Pandey - Director
The latest financial statements of Indianarise Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Indianarise Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Indianarise Pharmaceuticals is U24233DL2014PTC265686. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indianarise Pharmaceuticals was incorporated on 03 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
Jeetendra Kumar was appointed as Director on 03 Mar 2014. Rajendra Parsad Pandey was appointed as Director on 03 Mar 2014. Shyam Pandey Narayan was appointed as Director on 03 Mar 2014. Indianarise Pharmaceuticals has 4 board changes on record in total.
The registered office of Indianarise Pharmaceuticals is at House No. 363 First Floor Gali Chandi Wali Pahar Gan, J, New Delhi, Delhi, India – 110055.
Indianarise Pharmaceuticals operates in the chemicals industry, in the chemical products segment.
Indianarise Pharmaceuticals has open charges of ₹5 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
